Total Payments
$2,166
2024 Payments
$117.15
Companies
32
Transactions
146
Medicare Patients
1,274
Medicare Billing
$288,364
Payment Breakdown by Category
Food & Beverage$2,162 (99.8%)
Education$4.15 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,162 | 144 | 99.8% |
| Education | $4.15 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Indivior Inc. | $314.93 | 19 | $0 (2020) |
| PFIZER INC. | $298.75 | 25 | $0 (2020) |
| Lilly USA, LLC | $227.18 | 14 | $0 (2024) |
| GlaxoSmithKline, LLC. | $146.62 | 10 | $0 (2020) |
| Novo Nordisk Inc | $145.31 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $144.83 | 11 | $0 (2019) |
| Orexo US, Inc. | $136.36 | 8 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $96.61 | 7 | $0 (2020) |
| Amgen Inc. | $67.18 | 4 | $0 (2018) |
| Kowa Pharmaceuticals America, Inc. | $57.24 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $117.15 | 6 | ABBVIE INC. ($51.98) |
| 2023 | $14.63 | 1 | Otsuka America Pharmaceutical, Inc. ($14.63) |
| 2020 | $188.82 | 12 | AstraZeneca Pharmaceuticals LP ($44.47) |
| 2019 | $709.37 | 46 | Indivior Inc. ($161.69) |
| 2018 | $652.20 | 45 | PFIZER INC. ($92.79) |
| 2017 | $483.90 | 36 | PFIZER INC. ($122.47) |
All Payment Transactions
146 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Biological | ||||||
| 04/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Obesity | ||||||
| 11/29/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: PSYCHIATRY | ||||||
| 03/03/2020 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: OUD | ||||||
| 02/27/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/26/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: Diabetes | ||||||
| 02/19/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: UROLOGY | ||||||
| 02/12/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Diabetes | ||||||
| 02/06/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/30/2020 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Diabetes | ||||||
| 01/29/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: NEUROSCIENCE | ||||||
| 01/21/2020 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: OUD | ||||||
| 01/16/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/09/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: RESPIRATORY | ||||||
| 01/02/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/18/2019 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: OUD | ||||||
| 12/18/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $11.04 | General |
| Category: Cardiovascular | ||||||
| 12/12/2019 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $10.49 | General |
| Category: Diabetes | ||||||
| 11/27/2019 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: Opioid Analgesic | ||||||
| 11/20/2019 | Lilly USA, LLC | BASAGLAR (Drug), TRULICITY, JARDIANCE | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Diabetes | ||||||
| 11/19/2019 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: OUD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 383 | 1,184 | $198,440 | $68,027 |
| 2022 | 3 | 95 | 825 | $153,140 | $58,035 |
| 2021 | 6 | 502 | 2,394 | $181,422 | $132,420 |
| 2020 | 7 | 294 | 577 | $42,608 | $29,882 |
Total Patients
1,274
Total Services
4,980
Medicare Billing
$288,364
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 323 | $63,725 | $21,689 | 34.0% |
| 98928 | Osteopathic manipulative treatment, 7-8 body regions | Office | 2023 | 41 | 407 | $57,168 | $21,462 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 203 | $56,998 | $18,508 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $8,970 | $2,257 | 25.2% |
| 98925 | Osteopathic manipulative treatment, 1-2 body regions | Office | 2023 | 19 | 31 | $3,813 | $740.28 | 19.4% |
| 82670 | Measurement of total estradiol (hormone) | Office | 2023 | 13 | 13 | $806.00 | $355.94 | 44.2% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 13 | 13 | $611.00 | $328.77 | 53.8% |
| 84402 | Testosterone (hormone) level, free | Office | 2023 | 13 | 13 | $624.00 | $324.48 | 52.0% |
| 82627 | Dehydroepiandrosterone (dhea-s) hormone level | Office | 2023 | 13 | 13 | $663.00 | $283.27 | 42.7% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2023 | 13 | 13 | $624.00 | $276.90 | 44.4% |
| 84144 | Progesterone (reproductive hormone) level | Office | 2023 | 13 | 13 | $624.00 | $265.72 | 42.6% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 15 | 16 | $608.00 | $265.60 | 43.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 14 | 15 | $585.00 | $246.90 | 42.2% |
| 82533 | Cortisol (hormone) measurement, total | Office | 2023 | 14 | 14 | $588.00 | $223.58 | 38.0% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 14 | 14 | $602.00 | $206.92 | 34.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 16 | 19 | $285.00 | $159.60 | 56.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 14 | 15 | $465.00 | $155.25 | 33.4% |
| 83525 | Insulin measurement, total | Office | 2023 | 13 | 13 | $351.00 | $145.60 | 41.5% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 14 | 15 | $330.00 | $132.60 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 32 | 273 | $68,875 | $25,962 | 37.7% |
| 98928 | Osteopathic manipulative treatment, 7-8 body regions | Office | 2022 | 35 | 398 | $55,720 | $21,655 | 38.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 154 | $28,545 | $10,418 | 36.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 118 | 883 | $65,465 | $48,693 | 74.4% |
| 98927 | Osteopathic manipulative treatment to 5-6 body regions | Office | 2021 | 122 | 646 | $38,612 | $28,176 | 73.0% |
| 98928 | Osteopathic manipulative treatment to 7-8 body regions | Office | 2021 | 103 | 504 | $37,563 | $27,263 | 72.6% |
About Dr. Joshua Goodrum, DO
Dr. Joshua Goodrum, DO is a Family Medicine healthcare provider based in Ashland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1538318233.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Goodrum, DO has received a total of $2,166 in payments from pharmaceutical and medical device companies, with $117.15 received in 2024. These payments were reported across 146 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($2,162).
As a Medicare-enrolled provider, Goodrum has provided services to 1,274 Medicare beneficiaries, totaling 4,980 services with total Medicare billing of $288,364. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Neuromusculoskeletal Medicine & OMM
- Location Ashland, OR
- Active Since 09/17/2008
- Last Updated 02/15/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1538318233
Products in Payments
- SUBLOCADE (Drug) $284.38
- CHANTIX (Drug) $192.93
- Zubsolv (Drug) $136.36
- XARELTO (Drug) $131.44
- BASAGLAR (Drug) $85.69
- TRULICITY (Drug) $70.70
- FARXIGA (Drug) $66.79
- Ozempic (Drug) $64.24
- Livalo (Drug) $57.24
- TRELEGY ELLIPTA (Drug) $54.94
- LYRICA (Drug) $53.42
- BREO (Drug) $43.67
- JARDIANCE (Drug) $40.71
- ELIQUIS (Drug) $39.58
- FORTEO (Drug) $37.24
- TOUJEO (Drug) $36.33
- Aimovig (Biological) $34.73
- ANORO (Drug) $32.56
- QULIPTA (Drug) $31.40
- SUBOXONE SUBLINGUAL FILM (Drug) $30.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Ashland
Dr. Derek Jones, D.o, D.O
Family Medicine — Payments: $65,426
Family Medicine $65,426
Jackie Kazee, Md, MD
Family Medicine — Payments: $47,296
Family Medicine $47,296
Ryan Brang, Md, MD
Family Medicine — Payments: $27,480
Family Medicine $27,480
Rancie Hannah, Md, MD
Family Medicine — Payments: $16,929
Family Medicine $16,929
Dr. Abbe Cassity, D.o, D.O
Family Medicine — Payments: $15,073
Family Medicine $15,073
Larry Fields, Md, MD
Family Medicine — Payments: $13,964
Family Medicine $13,964